Dendrimers functionalized with membrane-interacting peptides for viral inhibition

Int J Nanomedicine. 2013:8:521-34. doi: 10.2147/IJN.S37739. Epub 2013 Feb 5.

Abstract

This contribution reports the synthesis of a poly(amide)-based dendrimer functionalized at the termini with a membrane-interacting peptide derived from the herpes simplex virus (HSV) type 1 glycoprotein H, namely gH625-644. This peptide has been shown to interact with model membranes and to inhibit viral infectivity. The peptidodendrimer inhibits both HSV-1 and HSV-2 at a very early stage of the entry process, most likely through an interaction with the viral envelope glycoproteins; thus, preventing the virus from coming into close contact with cellular membranes, a prerequisite of viral internalization. The 50% inhibitory concentration was 100 and 300 nM against HSV-1 and HSV-2 respectively, with no evidence of cell toxicity at these concentrations. These results show that the functionalization of a dendrimer with the peptide sequence derived from an HSV glycoprotein shows promising inhibitory activity towards viruses of the Herpesviridae family.

Keywords: antiviral activity; membranotropic peptides; peptidodendrimer.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antiviral Agents / chemistry*
  • Antiviral Agents / pharmacology
  • Apoptosis / drug effects
  • Chlorocebus aethiops
  • Dendrimers / chemistry*
  • Dendrimers / pharmacology
  • Herpesvirus 1, Human / drug effects*
  • Herpesvirus 1, Human / physiology
  • Molecular Sequence Data
  • Peptides / chemistry*
  • Peptides / pharmacology
  • Vero Cells
  • Viral Envelope Proteins / chemistry*
  • Viral Envelope Proteins / pharmacology
  • Virus Internalization / drug effects*

Substances

  • Antiviral Agents
  • Dendrimers
  • Peptides
  • Viral Envelope Proteins
  • glycoprotein H, herpes simplex virus type 1